These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

351 related items for PubMed ID: 8558940

  • 21. Establishing the presence of the t(15;17) in suspected acute promyelocytic leukaemia: cytogenetic, molecular and PML immunofluorescence assessment of patients entered into the M.R.C. ATRA trial. M.R.C. Adult Leukaemia Working Party.
    Grimwade D, Howe K, Langabeer S, Davies L, Oliver F, Walker H, Swirsky D, Wheatley K, Goldstone A, Burnett A, Solomon E.
    Br J Haematol; 1996 Sep; 94(3):557-73. PubMed ID: 8790159
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Clinical relevance of the PML/RAR-a gene rearrangement in acute promyelocytic leukaemia.
    Lo Coco F, Pelicci PG, Biondi A.
    Leuk Lymphoma; 1994 Feb; 12(5-6):327-32. PubMed ID: 8180596
    [Abstract] [Full Text] [Related]

  • 24. Autologous bone marrow transplantation for acute promyelocytic leukemia in second remission: prognostic relevance of pretransplant minimal residual disease assessment by reverse-transcription polymerase chain reaction of the PML/RAR alpha fusion gene.
    Meloni G, Diverio D, Vignetti M, Avvisati G, Capria S, Petti MC, Mandelli F, Lo Coco F.
    Blood; 1997 Aug 01; 90(3):1321-5. PubMed ID: 9242568
    [Abstract] [Full Text] [Related]

  • 25. Molecular diagnosis and monitoring of acute promyelocytic leukemia treated with retinoic acid.
    Levine K, DeBlasio A, Miller WH.
    Leukemia; 1994 Apr 01; 8 Suppl 1():S116-20. PubMed ID: 8152276
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. RT-PCR in acute promyelocytic leukemia: second workshop of the European Retinoic Group, Paris, France, 17-18 December 1994.
    Leukemia; 1996 Feb 01; 10(2):368-71. PubMed ID: 8637250
    [Abstract] [Full Text] [Related]

  • 31. Rapid diagnosis of acute promyelocytic leukemia with the PML-RARA fusion gene using a combination of droplet-reverse transcription-polymerase chain reaction and instant-quality fluorescence in situ hybridization.
    Shigeto S, Matsuda K, Yamaguchi A, Sueki A, Uehara M, Sugano M, Uehara T, Honda T.
    Clin Chim Acta; 2016 Jan 30; 453():38-41. PubMed ID: 26656442
    [Abstract] [Full Text] [Related]

  • 32. PML/RAR alpha fusion gene is expressed in both granuloid/macrophage and erythroid colonies in acute promyelocytic leukaemia.
    Takatsuki H, Sadamura S, Umemura T, Abe Y, Goto T, Yufu Y, Katsuno M, Hirata J, Nishimura J, Nawata H.
    Br J Haematol; 1993 Nov 30; 85(3):477-82. PubMed ID: 8136268
    [Abstract] [Full Text] [Related]

  • 33. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP.
    Oncogene; 2006 Mar 23; 25(13):1974-9. PubMed ID: 16331271
    [Abstract] [Full Text] [Related]

  • 34. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
    Rousselot P, Hardas B, Patel A, Guidez F, Gäken J, Castaigne S, Dejean A, de Thé H, Degos L, Farzaneh F.
    Oncogene; 1994 Feb 23; 9(2):545-51. PubMed ID: 8290265
    [Abstract] [Full Text] [Related]

  • 35. Detection of PML-retinoic acid receptor-alpha fusion transcripts in acute promyelocytic leukemia with trisomy 8 but without t(15;17).
    Ikeda K, Sasaki K, Tasaka T, Nagai M, Kawanishi K, Takahara J, Irino S.
    Am J Hematol; 1994 Mar 23; 45(3):212-6. PubMed ID: 8296791
    [Abstract] [Full Text] [Related]

  • 36. [Study on conversion of RARalpha/PML fusion gene in acute promyelocytic leukemia].
    Liu Y, Le X, Xue W, Yu X, Guo N, Lu D, Chen S.
    Zhonghua Xue Ye Xue Za Zhi; 1997 Aug 23; 18(8):400-2. PubMed ID: 15625843
    [Abstract] [Full Text] [Related]

  • 37. Acute promyelocytic leukaemia and the t(15;17) translocation.
    Gillard EF, Solomon E.
    Semin Cancer Biol; 1993 Dec 23; 4(6):359-67. PubMed ID: 8142621
    [Abstract] [Full Text] [Related]

  • 38. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
    Grignani F, Testa U, Fagioli M, Barberi T, Masciulli R, Mariani G, Peschle C, Pelicci PG.
    Cancer Res; 1995 Jan 15; 55(2):440-3. PubMed ID: 7529139
    [Abstract] [Full Text] [Related]

  • 39. Sequential targeted therapy for relapsed acute promyelocytic leukemia with all-trans retinoic acid and anti-CD33 monoclonal antibody M195.
    Jurcic JG, Caron PC, Miller WH, Yao TJ, Maslak P, Finn RD, Larson SM, Warrell RP, Scheinberg DA.
    Leukemia; 1995 Feb 15; 9(2):244-8. PubMed ID: 7869759
    [Abstract] [Full Text] [Related]

  • 40. PML-RAR alpha PCR positivity in the bone marrow of patients with APL precedes haematological relapse by 2-3 months.
    Korninger L, Knöbl P, Laczika K, Mustafa S, Quehenberger P, Schwarzinger I, Lechner K, Jaeger U, Mannhalter C.
    Br J Haematol; 1994 Oct 15; 88(2):427-31. PubMed ID: 7803299
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 18.